A Study of HDM1002 in Subjects With And Without Varying Degrees Of Hepatic Impairement

Clinical trial NCT06985615 · RECRUITING

Trial details

NCT number: NCT06985615
Sponsor: Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Hepatic Impairment Healthy Volunteers

Start date: 2025-03-18
Primary completion: 2026-01-14
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.